Find a CARTICEL Specialist

The Surgeon Locator can provide you with the names, addresses and phone numbers of specialists and orthopedic surgeons who have experience with the CARTICEL implantation procedure. You can search for surgeons who use CARTICEL by selecting a state from the drop down list below. If you live close to another state, you may want to search by that state or by ZIP code as well.

If your doctor's name does not appear on the list provided, it does not necessarily mean that he or she has not been trained or does not have experience with CARTICEL.

You could also browse to find surgeons listed by state.

Search by City and State or ZIP Code.

City:

State:

OR

Zip Code:

Miles:

This search tool is provided for your information only; it is not an endorsement of or referral to any surgeons listed. Genzyme Biosurgery is not suggesting that the surgeons listed herein should be substituted for any other surgeons you may consult. The surgeons listed here can be consulted to see if CARTICEL may be right for you.

Indication

Carticel® (autologous cultured chondrocytes) is an autologous cellular product indicated for the repair of symptomatic cartilage defects of the femoral condyle (medial, lateral or trochlea), caused by acute or repetitive trauma, in patients who have had an inadequate response to a prior arthroscopic or other surgical repair procedure (e.g., debridement, microfracture, drilling/abrasion arthroplasty, or osteochondral allograft/autograft).

CARTICEL should only be used in conjunction with debridement, placement of a periosteal flap and rehabilitation. The independent contributions of the autologous cultured chondrocytes and other components of the therapy to outcome are unknown.

CARTICEL is not indicated for the treatment of cartilage damage associated with generalized osteoarthritis.

CARTICEL is not recommended for patients with total meniscectomy unless surgically reconstructed prior to or concurrent with CARTICEL implantation.

Important Safety Information

CARTICEL should not be used in patients with a known history of hypersensitivity to gentamicin, other aminoglycosides or materials of bovine origin.

It should not be used in patients who have previously had cancer in the bones, cartilage, fat or muscle of the treated limb.

Pre-existing conditions, including meniscal tears, joint instability, or malalignment should be assessed and treated prior to or concurrent with CARTICEL implantation.

CARTICEL is not routinely tested for transmissible infectious diseases and may transmit disease to the healthcare provider handling CARTICEL.

Use of CARTICEL in children, patients over age 65, or in joints other than the knee has not yet been assessed.

The occurrence of subsequent surgical procedures (SSPs), primarily arthroscopy, following CARTICEL implantation is common. In the Study of the Treatment of Articular Repair (STAR), forty-nine percent (49%) of patients underwent an SSP on the treated knee, irrespective of their relationship to CARTICEL, during the 4-year follow up. The most common serious adverse events (≥5% of patients), derived from STAR, include arthrofibrosis/joint adhesions, graft overgrowth, chondromalacia or chondrosis, cartilage injury, graft complication, meniscal lesion, graft delamination, and osteoarthritis.

For more information on CARTICEL, please see the Package Insert (PDF).

Ready to proceed with CARTICEL? You’re already on the right path.

I'm Ready